Using intranasal dexmedetomidine to manage pain during eye exams in premature infants
Official title: Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity: a Crossover Randomized Controlled Trial
Run by Assaf-Harofeh Medical Center · NCT06067958 · Data updated 2026-11-12
This study tests if a nasal spray of dexmedetomidine can help reduce pain for premature infants during eye exams.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 4 Weeks and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Assaf-Harofeh Medical Center Government |
| Locations | 1 site (Be’er Ya‘aqov, Center) |
| Status | Recruiting |
| Started | December 11, 2023 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06067958 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are preterm infants with a gestational age of less than 31 weeks or a birth weight of less than 1500 grams.
✕Probably not a fit
Patients who are on invasive ventilation or have multiple congenital or genetic anomalies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of intranasal dexmedetomidine for pain management in preterm infants undergoing eye examinations for retinopathy of prematurity. The study compares the pain scores of infants receiving dexmedetomidine to those receiving a placebo (saline 0.9%) administered 30 minutes prior to the examination. Participants will be closely monitored for pain relief and any potential adverse effects. The goal is to improve pain management during these critical assessments, which are known to cause significant discomfort.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and stress for preterm infants during necessary eye examinations.
How similar studies have gone: While there is limited data on the use of dexmedetomidine specifically for this purpose, similar approaches in pain management for infants have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age \< 31 weeks post-menstrual age, or birth weight \< 1500 grams * Informed consent signed by one of the parents Exclusion Criteria: * Invasive ventilation at the time of the eye assessment * Multiple congenital anomalies * Chromosomal / genetic anomalies * Infant received a sedative drug in last 5 days * Eye examination for reasons other than retinopathy of prematurity screening * Attending physician deemed the patient not stable enough
Where it's running
-
Assaf-Harofeh Medical Center
Be’er Ya‘aqov, Center, Israel Recruiting
Study contacts
- Study coordinator: Sagee Nissimov, MD
- Email: sageen@shamir.gov.il
- Phone: 97289779080
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery
This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced
This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.
-
Incidence of hypoxia during intravitreal ranibizumab injections for retinopathy of prematurity under topical anesthesia
This study looks at how often and how severely babies with retinopathy of prematurity experience low oxygen levels during bedside eye injections with topical anesthesia.
-
Dexmedetomidine vs magnesium as intraperitoneal add-ons to bupivacaine for laparoscopic gallbladder removal
This study tests whether adding dexmedetomidine or magnesium sulfate to bupivacaine injected inside the abdomen provides better pain relief after laparoscopic cholecystectomy for adults without serious health issues.
-
Dexmedetomidine vs magnesium with lidocaine for eye block during DCR surgery
This trial tests whether adding dexmedetomidine or magnesium sulfate to lidocaine for a preemptive peribulbar block can better manage blood pressure and heart rate in adults undergoing DCR surgery under general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.